HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Neurochem’s Supplement Launch In U.S. On Hold Due To DSHEA Question

This article was originally published in The Tan Sheet

Executive Summary

Neurochem plans to launch a failed Alzheimer's drug candidate as a dietary supplement in Canada this year and in Europe and Japan in 2009, but has not determined whether it will make the product available in theU.S., company executives said Feb. 21

You may also be interested in...

People In Brief

NCCAM advisors: The National Center for Complementary and Alternative Medicine names six members to four-year terms on its national advisory council, which meets three times a year to offer advice and recommendations on conduct, support and prioritization of CAM research. The new members are Timothy C. Birdsall, vice president for integrative medicine at the Cancer Treatment Centers of America in Zion, Ill.; Boyd W. Bowden II, on the orthopedics staff at Doctors Hospital and at Orthopedic and Neurological Consultants Inc., in Columbus, Ohio; Gert Bronfort, a professor and associate vice president of research at Northwestern Health Sciences University, Bloomington, Minn., where he is also senior clinical researcher at the Wolfe-Harris Center for Clinical Studies; Lupo T. Carlota, president and founder of the Medical Acupuncture Research Institute of America in Memphis, Tenn.; Shin Lin, a professor of developmental and cell biology, physiology and biophysics and biomedical engineering at the University of California-Irvine, and a member of the advisory board and faculty of the university's Susan Samueli Center for Integrative Medicine; and Herman A. Taylor Jr., a professor of medicine and attending physician in the Division of Cardiovascular Diseases and Internal Medicine at the University of Mississippi Medical Center in Jackson...

Neurochem Faces Obstacles To Making Supplement Out Of Drug Candidate

Neurochem's plan to market a failed Alzheimer's disease drug candidate as a dietary supplement could stumble in the United States over requirements of the Dietary Supplement Health and Education Act, regulatory experts say

OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study

Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts